BRPI1011630A2 - paracetamol para a administração parenteral - Google Patents

paracetamol para a administração parenteral

Info

Publication number
BRPI1011630A2
BRPI1011630A2 BRPI1011630A BRPI1011630A BRPI1011630A2 BR PI1011630 A2 BRPI1011630 A2 BR PI1011630A2 BR PI1011630 A BRPI1011630 A BR PI1011630A BR PI1011630 A BRPI1011630 A BR PI1011630A BR PI1011630 A2 BRPI1011630 A2 BR PI1011630A2
Authority
BR
Brazil
Prior art keywords
acetaminophen
parenteral administration
parenteral
administration
Prior art date
Application number
BRPI1011630A
Other languages
English (en)
Inventor
Christine Aichholzer
David Dasberg
Georg Achleitner
Original Assignee
Fresenius Kabi De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41066778&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1011630(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh
Publication of BRPI1011630A2 publication Critical patent/BRPI1011630A2/pt
Publication of BRPI1011630B1 publication Critical patent/BRPI1011630B1/pt
Publication of BRPI1011630B8 publication Critical patent/BRPI1011630B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI1011630A 2009-04-22 2010-04-19 paracetamol para a administração parenteral BRPI1011630B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09005630.0 2009-04-22
EP20090005630 EP2243477A1 (de) 2009-04-22 2009-04-22 Paracetamol zur parenteralen Verabreichung
PCT/EP2010/002368 WO2010121762A1 (de) 2009-04-22 2010-04-19 Paracetamol zur parenteralen verabreichung

Publications (3)

Publication Number Publication Date
BRPI1011630A2 true BRPI1011630A2 (pt) 2016-03-22
BRPI1011630B1 BRPI1011630B1 (pt) 2020-06-23
BRPI1011630B8 BRPI1011630B8 (pt) 2021-05-25

Family

ID=41066778

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1011630A BRPI1011630B8 (pt) 2009-04-22 2010-04-19 paracetamol para a administração parenteral

Country Status (13)

Country Link
US (2) US8741959B2 (pt)
EP (3) EP2243477A1 (pt)
JP (1) JP2012524738A (pt)
CN (1) CN102421426A (pt)
AU (1) AU2010238854B2 (pt)
BR (1) BRPI1011630B8 (pt)
DK (2) DK2626068T3 (pt)
ES (2) ES2564547T3 (pt)
HK (1) HK1166957A1 (pt)
HU (1) HUE026823T2 (pt)
PL (2) PL2421522T3 (pt)
PT (1) PT2421522E (pt)
WO (1) WO2010121762A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121154A1 (it) 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
EA028075B1 (ru) * 2014-04-29 2017-10-31 Мыкола Ивановыч ГУМЕНЮК Фармацевтическая композиция
WO2016008546A1 (en) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2016013049A1 (en) * 2014-07-25 2016-01-28 Terumo Kabushiki Kaisha Packaged acetaminophen injection solution preparation
EP3120837A1 (de) 2015-07-22 2017-01-25 Stada Arzneimittel Ag Verfahren zur herstellung einer bortezomibester-lösung
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD279405A1 (de) 1989-01-10 1990-06-06 Berlin Chemie Veb Verfahren zur herstellung eines parenteral applizierbaren analgetikums/antipyretikums
KR930011994B1 (ko) * 1991-08-16 1993-12-23 대광제약 주식회사 파라세타몰의 생체이용율을 높이는 방법 및 이 생체이용율이 높아진 파라세타몰을 함유한 제제
US5252313A (en) 1991-12-20 1993-10-12 Colgate-Palmolive Company Visually clear gel dentifrice
JP3913795B2 (ja) * 1995-09-28 2007-05-09 エスエス製薬株式会社 安定な解熱鎮痛剤配合液剤
JPH09286724A (ja) * 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 経口用安定液剤
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
PT916347E (pt) 1997-11-18 2003-07-31 Uni Pharma Kleon Tsetis A B E Solucoes farmaceuticas injectaveis contendo paracetamol e combinacoes de paracetamol com outras substancias activas
JPH11279046A (ja) * 1998-03-30 1999-10-12 Shiseido Co Ltd 皮膚外用剤
IT1301976B1 (it) * 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
IT1313579B1 (it) * 1999-07-30 2002-09-09 Acraf Composizione farmaceutica liquida a base di paracetamolo.
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
KR100405161B1 (ko) * 2000-12-14 2003-11-12 신풍제약주식회사 록소프로펜 함유 근육주사제 조성물
DE10112325A1 (de) 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
HUP0402549A3 (en) 2001-12-18 2006-01-30 Tseti Ioulia Parenteral composition of paracetamol
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
JP4358535B2 (ja) * 2003-03-05 2009-11-04 昭和薬品化工株式会社 アセトアミノフェンを含有する安定な水性医薬組成物
AU2006309295B2 (en) 2005-06-03 2012-04-26 Elan Pharma International Limited Nanoparticulate acetaminophen formulations
DE102005037653A1 (de) 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
AU2006346318B2 (en) * 2006-07-18 2011-02-10 Genfarma Laboratorio S.L. Injectable liquid paracetamol formulation
CN101015542A (zh) * 2007-02-13 2007-08-15 天津生机集团有限公司 家畜用复方对乙酰氨基酚注射液及其制备方法
EP1992334A1 (en) * 2007-05-08 2008-11-19 Docpharma NV/SA Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
EP2170313A2 (en) * 2007-06-18 2010-04-07 Combino Pharm, S.L. Aqueous formulations of acetaminophen for injection
US9399012B2 (en) * 2007-11-13 2016-07-26 Mallinckrodt Ip Reduced dose intravenous acetaminophen
WO2009098716A2 (en) * 2008-01-17 2009-08-13 Aptuit Laurus Private Limited Stable pharmaceutical aqueous compositions
CN101366695A (zh) * 2008-10-16 2009-02-18 江苏四环生物股份有限公司 扑热息痛注射液及其制备方法
US20120245230A1 (en) * 2009-12-10 2012-09-27 Tecnimede-Sociedade Tecnico- Medicinal, S.A. Method and composition for preparing stable liquid formulations of paracetamol

Also Published As

Publication number Publication date
EP2421522A1 (de) 2012-02-29
ES2415354T3 (es) 2013-07-25
HK1166957A1 (en) 2012-11-16
CN102421426A (zh) 2012-04-18
AU2010238854B2 (en) 2015-04-30
US20150105471A1 (en) 2015-04-16
BRPI1011630B8 (pt) 2021-05-25
PL2626068T3 (pl) 2016-09-30
EP2421522B1 (de) 2013-04-03
BRPI1011630B1 (pt) 2020-06-23
EP2626068B1 (de) 2015-12-09
AU2010238854A1 (en) 2011-11-17
DK2421522T3 (da) 2013-07-08
EP2243477A1 (de) 2010-10-27
US8741959B2 (en) 2014-06-03
HUE026823T2 (en) 2016-07-28
JP2012524738A (ja) 2012-10-18
PT2421522E (pt) 2013-07-08
PL2421522T3 (pl) 2013-08-30
US20120035267A1 (en) 2012-02-09
DK2626068T3 (en) 2016-02-29
WO2010121762A1 (de) 2010-10-28
ES2564547T3 (es) 2016-03-23
EP2626068A1 (de) 2013-08-14

Similar Documents

Publication Publication Date Title
BRPI1013639A2 (pt) medicamentos antidiabéticos
DK2620428T3 (da) Asymmetrisk hjælpegruppe
IT1394860B1 (it) Composti farmaceutici
DK3037536T3 (da) Oligonukleotiderstatning for di-taggede og retnings biblioteker
DK3184136T3 (da) Injektor
BR112013029138A2 (pt) procedimento para assinatura digital múltipla
ITMI20121896A1 (it) Mems-chippackage e procedimento per fabbricare un mems-chippackage
BRPI0908416A2 (pt) Seringa para injeção
FR2958801B1 (fr) Biopile a glucose
IT1398669B1 (it) Set di infusione con ago retrattile
DK2582416T3 (da) Holder til en injektionssprøjte
BRPI1009191A2 (pt) dispositivo para administração intranasal
IT1393930B1 (it) Composti farmaceutici
BRPI1011630A2 (pt) paracetamol para a administração parenteral
BR112012001294A2 (pt) métodos para prover feição em agulha
DK2566838T3 (da) Forbindelser med en trænote
CO6900137A2 (es) Comprimido masticable de ibuprofeno
BR112013013309A2 (pt) processos para a preparação de enaminas
BR112013013303A2 (pt) processos para a preparação de enaminas
BR112013000898A2 (pt) disposição para uma trava
IT1398163B1 (it) Innesco a carica ridotta
ES1070148Y (es) Macolla para barrotes mejorada
ITMI20100232A1 (it) Composti farmaceutici
FR2978220B1 (fr) Embrayage bi-disque a element d'appui embouti
FR2978133B1 (fr) Tire-bouchon a double point d'appui

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/06/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/04/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF